Article type:
News
Estimated read time:
1 min min read
Published:
20/06/2024
A gene therapy treatment for haemophilia B that costs £2.6 million per patient is now available on the NHS. The treatment is being made available through a deal between the company CSL Behring, NHS England and the National Institute of Health and Care Excellence, the body that rules on cost-effectiveness.